US Stocks
/
MapLight Therapeutics, Inc. Share Price

MapLight Therapeutics, Inc. Share Price

NASDAQ: MPLT | Micro Cap
$9.13
-$0.24 (-2.56%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

MapLight Therapeutics, Inc. Stock Performance

Open
$9.18
Prev. Close
$9.37
Circuit Range
N/A
Day Range
$9.03 - $9.22
Year Range
$9.02 - $39.82
Volume
15,113
Average Traded
$9.13

MapLight Therapeutics, Inc. Share Price Today

As of 9 October 2026, MapLight Therapeutics, Inc.'s share price is $9.13. The stock opened at $9.18, compared to its previous close of $9.37. During today's trading session, MapLight Therapeutics, Inc.'s share price traded between $9.03 and $9.22, with an average price of $9.13. Over the past 52 weeks, the stock has recorded a high of $39.82 and a low of $9.02. In terms of performance, MapLight Therapeutics, Inc.'s share price has declined by 71.24% over the last six months and is down 46.31% on a year-on-year basis.

MapLight Therapeutics, Inc. Share Price Chart

$9.03$9.22
L
Show Current Price
H

MapLight Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$79.26M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-4.14
Revenue (TTM)
$0.00
Return On Equity (TTM)
-65.99%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
N/A

MapLight Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00
Net Profit-$79.55-$60.67-$60.19
Net Profit MarginN/AN/AN/A
Income ChangeN/A23.73%0.79%

MapLight Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.00
Net Profit-$161.15
Net Profit MarginN/A
Income ChangeN/A

About MapLight Therapeutics, Inc.

MapLight Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing treatments for central nervous system disorders. Its discovery platform identifies neural circuits causally linked to disease and targets them for therapeutic modulation, aiming to improve efficacy, safety, tolerability, and ease of use. The company was founded by leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies. Its product candidate, ML-007C-MA, is a fixed-dose combination of an M1/M4 muscarinic agonist and a peripherally acting anticholinergic, being developed for schizophrenia and Alzheimer's disease psychosis, designed to activate central receptors while mitigating peripheral side effects.

MapLight Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$10.12
$9.19
-9.90%
Sep 2026
$12.95
$10.20
-18.40%
Aug 2026
$12.70
$12.50
-4.03%
Jul 2026
$34.43
$13.03
-63.68%
Jun 2026
$28.73
$35.86
+22.26%
May 2026
$31.48
$29.33
-7.62%
Apr 2026
$21.00
$31.75
+56.02%
Mar 2026
$17.50
$20.35
+17.77%
Feb 2026
$17.45
$17.28
-2.37%
Jan 2026
$17.29
$17.70
+0.97%
Dec 2025
$13.19
$17.53
+27.54%
Nov 2025
$16.80
$13.74
-19.17%

MPLT Share Price FAQs

What is MapLight Therapeutics, Inc. share price today?

chevron-up
MapLight Therapeutics, Inc. share price today is $9.13 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of MapLight Therapeutics, Inc. stock?

chevron-up
The 52 week high of MapLight Therapeutics, Inc. stock is $39.82, while the 52 week low is $9.02 as of 9 Oct '26.

What is MPLT's market capitalisation today?

chevron-up
MPLT market capitalisation is $79.26M as of October 9, 2026, at 11:45 am IST.

What is MPLT's net income for the last quarter?

chevron-up
MPLT's net income for the last quarter is -60.19B USD.

What is the 5 year returns of MPLT?

chevron-up
The 5 year returns of MPLT is -46.31% as on 9 Oct '26.

What is the high & low stock price of MPLT today?

chevron-up
MPLT stock price hit a high of $9.22 and low of $9.03 as of 9 Oct '26.

Can I buy MPLT shares in India?

chevron-up
Yes. You can buy MPLT in India by opening an international trading account.